AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Director's Dealing 2012

Nov 30, 2012

6965_dirs_2012-11-30_00bc7088-8756-4e62-8a14-b5ca2b96558e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2008-07-17

Reporting Person: JACOB HAROLD (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect

Footnotes

F1: This Form 3 amendment is being filed to report 10,000 shares of Common Stock of the Issuer indirectly acquired by Mr. Harold Jacob through a wholly-owned corporation, prior to his appointment to the Issuer's board of directors on July 17, 2008.